REPORT: Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics
In August 2019, the Antibody Engineering & Therapeutics conference series conducted a survey of industry professionals from pharma, biotechs, academia, CDMOs, CROs, service providers and consultancies around the world.
This report, based on 211 responses, provides an inside snapshot of the key challenges and hottest opportunities around emerging technologies and novel approaches in antibody engineering and therapeutics.
